We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUE icon
201
Nucor
NUE
$62.5B
$82K 0.01%
500
– –
ITW icon
202
Illinois Tool Works
ITW
$85.2B
$79.3K 0.01%
317
– –
RSP icon
203
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
$74.5K 0.01%
498
– –
ORLY icon
204
O'Reilly Automotive
ORLY
$76B
$71.6K 0.01%
1,125
– –
PANW icon
205
Palo Alto Networks
PANW
$297B
$69.8K 0.01%
546
+96
+21% +$9.99K
IWO icon
206
iShares Russell 2000 Growth ETF
IWO
$15B
$68.4K 0.01%
+282
New +$64.7K
MDT icon
207
Medtronic
MDT
$109B
$68.3K 0.01%
775
– –
DOW icon
208
Dow Inc
DOW
$21.3B
$67.9K 0.01%
1,275
+175
+16% +$9.3K
MRK icon
209
Merck
MRK
$318B
$66.9K 0.01%
580
+25
+5% +$2.84K
LIN icon
210
Linde
LIN
$226B
$65.5K 0.01%
172
-20
-10% -$7.3K
SPSM icon
211
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
$62.6K 0.01%
+1,611
New +$59.9K
GE icon
212
GE Aerospace
GE
$396B
$62.5K 0.01%
713
– –
MRNA icon
213
Moderna
MRNA
$22.8B
$60.8K 0.01%
500
– –
MBC icon
214
MasterBrand
MBC
$1.17B
$59.1K 0.01%
5,078
+278
+6% +$2.67K
BRBR icon
215
BellRing Brands
BRBR
$1.48B
$58.8K 0.01%
1,607
– –
ISRG icon
216
Intuitive Surgical
ISRG
$132B
$57.4K 0.01%
168
– –
CRM icon
217
Salesforce
CRM
$157B
$56.4K 0.01%
267
+252
+1,680% +$51.4K
D icon
218
Dominion Energy
D
$60.1B
$51.8K ﹤0.01%
1,000
– –
MDLZ icon
219
Mondelez International
MDLZ
$79.4B
$45.9K ﹤0.01%
629
– –
IWP icon
220
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
$44.5K ﹤0.01%
460
– –
CB icon
221
Chubb
CB
$135B
$44.3K ﹤0.01%
230
– –
WBA
222
DELISTED
Walgreens Boots Alliance
WBA
$42.7K ﹤0.01%
1,500
– –
SPSB icon
223
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
$42K ﹤0.01%
1,425
– –
ESLT icon
224
Elbit Systems
ESLT
$39.9B
$41.8K ﹤0.01%
200
– –
TYL icon
225
Tyler Technologies
TYL
$12.6B
$41.6K ﹤0.01%
100
– –
7 8
9
10 11

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.